CVS Health Corporation reports strong second quarter 2026 results and raises full‑year 2026 guidance

View print-friendly version (PDF)

• Second quarter total revenues increased to $106.1 billion, up 7.3% year-over-year
• Second quarter GAAP diluted EPS of $2.31 and Adjusted EPS of $2.58
• Generated year-to-date cash flow from operations of $10.6 billion
• Raising full-year 2026 guidance:
  • GAAP diluted EPS guidance range to $6.84 to $7.04 from $6.24 to $6.44
  • Adjusted EPS guidance range to $7.90 to $8.10 from $7.30 to $7.50
  • Cash flow from operations guidance to at least $11.5 billion from at least $9.5 billion

WOONSOCKET, RHODE ISLAND, August 5, 2026 - CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended June 30, 2026.

"Our CVS Health colleagues build trust every day in communities across our country by making healthcare easier for millions of customers, patients and members. As our businesses work together to deliver a technology-powered care engagement experience, we continue to deliver strong performance. We uniquely enable what our customers want the most: simple, connected and convenient access to affordable, quality healthcare, where, when, and how they want it."

- David Joyner, CVS Health Chairman and CEO